Ara
Toplam kayıt 108, listelenen: 41-50
Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
(Humana Press Inc, 2020)
As we know more about the clinical and laboratory features of COVID-19, which is now accepted as a pandemic, many questions have been raised about how to manage and monitor the treatment of cancer patients. It was determined ...
Use of complementary and alternative medicine and quality of life of cancer patients who received chemotherapy in Turkey
(Churchill Livingstone, 2019)
Objectives: This study aims to evaluate the frequency of use of CAM therapies among cancer patients, the types of CAM therapies they used, the demographic and clinical factors affecting their tendency to use CAM therapies, ...
A View from Young Oncologists on Clinical Trials in Turkey: Obstacles and Solution Proposals
(Akad Doktorlar Yayinevi, 2014)
There is a new improvement in oncology nearly in every day as a result of preclinical or clinical. As the number of publication per capita, Turkey is far behind the other developed European countries. For example, the ...
Multicenter Evaluation of Patients with Cutaneous Malignant Melanoma in Turkey: MELAS Study
(Asian Pacific Organization Cancer Prevention, 2013)
Background: Malignant melanoma is a cancer that demonstrates rapid progression and atypical clinically features with a poor prognosis. Aim: This study was performed to determine the clinical characteristics and treatment ...
Association of Helicobacter pylori infection with chemotherapy-induced thrombocytopenia in patients with stage III colon cancer: A pilot study
(Taylor & Francis Inc, 2014)
In this study, the effects of the pre-treatment presence of Helicobacter pylori (H. pylori) infection on chemotherapy-induced thrombocytopenia (CIT) were investigated in patients with stage III colon cancer (CC). A cohort ...
Evaluation of Cancer Patients Admitted to the Emergency Department within One Month before Death in Turkey: What are the Problems Needing Attention?
(Asian Pacific Organization Cancer Prevention, 2014)
Background: Although previously studies have reported that most patients with malignancy prefer to die at home, this is not the real situation in clinical practice. Aim: In this study, we aimed to determine the characteristics ...
Single Center Experience on Causes of Cancer Patients Visiting the Emergency Department in Southwest Turkey
(Asian Pacific Organization Cancer Prevention, 2014)
Background: Emergency departments are visited by cancer patients for palliation of cancer-related symptoms, management of treatment-related side effects, oncologic emergencies, co-morbidities, and/or end of life care. In ...
Predictive Value of Baseline Plasma D-dimers for Chemotherapy-induced Thrombocytopenia in Patients with Stage III Colon Cancer: A Pilot Study
(Asian Pacific Organization Cancer Prevention, 2013)
Background: : Chemotherapy-induced thrombocytopenia (CIT) is an important cause of morbitity in patients with cancer. Aim: To investigate the effect of the baseline plasma D-dimer level, an important marker for thrombotic ...
Long-term effect of trastuzumab on QT dispersion in adjuvant treatment for patients with Her2 receptor positive breast cancer: a pilot study
(Humana Press Inc, 2012)
We investigated the long-term effect of trastuzumab, a monoclonal antibody against the Her2 signalling pathway, on QT dispersion in female patients with early-stage breast cancer. A total of 46 eligible patients with ...
Complementary/Alternative Medicine Experience in Cancer Patients: A Questionnaire-Based Survey
(Akad Doktorlar Yayinevi, 2014)
A study was designed to evaluate the frequency of complementary/alternative therapy (CAM) knowledge and usage in cancer patients. A 23-item survey questionnaire was administered to 494 patients who received chemotherapy ...